Frequently Asked Questions
The market is segmented based on , By Product (Reagents, Consumables, Others), Technology (xMAP (Multi-Analyte Profiling), RT-PCR (Real Time Polymerase Chain Reaction), ELISA (Enzyme-Linked Immunosorbent Assay), Others), Application (Influenza A, Influenza B, Parainfluenza Viruses, Adenovirus, Respiratory Syncytial Virus (RSV), Coronaviruses, Human Metapneumovirus (hMPV), Group Rhino- and Enteroviruses), End User (Hospitals, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, Research Institutes, Others) – Industry Trends and Forecast to 2029.
.
The Global Multiplex Testing Market size was valued at USD 2.00 USD Billion in 2021.
The Global Multiplex Testing Market is projected to grow at a CAGR of 8.5% during the forecast period of 2022 to 2029.
The major players operating in the market include BD , bioMé,rieux SA , Bio-Rad LaboratoriesInc. , Thermo Fisher Scientific Inc. , Merck KGaA , IlluminaInc. , QIAGEN , Abcam plc. AGilent TechnologiesInc. , MESO SCALE DIAGNOSTICSLLC. , Randox Laboratories Ltd. , Quanterix , Bio-Techne. , Olink , Seegene Inc. .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
